Device company Smiths Medical has announced FDA 510(k) clearance for its CADD®-Solis VIP ambulatory infusion system with CADD™-Solis medication safety software.
Smiths Medical’s new CADD®-Solis VIP (variable infusion profile) system is a versatile, multiple therapy pump for applications including TPN, Intermittent, Continuous, PCA and Step. The company says its device features a large, therapy-specific color screen to help easily differentiate each delivery mode and provide intuitive, easy-to-use navigation. The on-board library holds up to 500 protocols, and pharmacist-defined soft and hard limits provide clinician control and medication safety.
“Our CADD® infusion systems have a long history of providing reliable and safe infusion delivery for home care patients,” said Srini Seshadri, President of Smiths Medical. “We are extremely pleased to be able to continue that tradition with a smart, innovative new system that will help home care providers to prevent pump programming errors and improve patient safety. The new CADD®-Solis VIP system provides enhanced safety features and convenience for health care providers who want to provide optimal care for their infusion patients in the home.”
The CADD®-Solis VIP system is currently available for sale in Canada, France, Germany, Switzerland, the Netherlands, Australia, the UK, and the Middle East.